Shuting Li Selected Research

Inflammation (Inflammations)

10/2023	Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions.
7/2023	Agomir miRNA-150-5p alleviates pristane-induced lupus by suppressing myeloid dendritic cells activation and inflammation via TREM-1 axis.
12/2022	Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
1/2021	Antioxidant and Inflammatory Effects of Nelumbo nucifera Gaertn. Leaves.
1/2020	Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
1/2020	Micheliolide Attenuates Lipopolysaccharide-Induced Inflammation by Modulating the mROS/NF-κB/NLRP3 Axis in Renal Tubular Epithelial Cells.
12/2019	Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuting Li Research Topics

Disease

38	Neoplasms (Cancer) 03/2024 - 07/2005
7	Peritoneal Fibrosis 02/2024 - 01/2019
7	Inflammation (Inflammations) 10/2023 - 12/2019
7	Fibrosis (Cirrhosis) 12/2022 - 01/2019
5	Lung Neoplasms (Lung Cancer) 03/2023 - 03/2022
4	Proteinuria 11/2023 - 12/2019
4	Hypertension (High Blood Pressure) 10/2023 - 03/2009
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2017
3	Wounds and Injuries (Trauma) 01/2024 - 01/2016
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 08/2018
3	Carcinogenesis 05/2023 - 12/2022
3	Adenocarcinoma of Lung 03/2023 - 09/2022
3	Medulloblastoma 01/2022 - 11/2018
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 12/2019
3	Severe Acute Respiratory Syndrome 08/2003 - 08/2003
2	Infections 03/2024 - 07/2013
2	Macular Edema 01/2024 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 09/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 06/2022
2	Hyperthermia 04/2023 - 12/2022
2	Thrombosis (Thrombus) 12/2022 - 11/2022
2	Ulcer 01/2022 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2016
2	Muscular Diseases (Myopathy) 04/2021 - 09/2020
1	Pain (Aches) 05/2024
1	Febrile Seizures (Febrile Seizure) 03/2024
1	Human Influenza (Influenza) 03/2024
1	Autistic Disorder (Autism) 01/2024
1	Microaneurysm 01/2024
1	Placenta Accreta 12/2023
1	Dacryocystitis (Dacryoadenitis) 11/2023
1	Chronic Renal Insufficiency 11/2023
1	Stroke (Strokes) 11/2023
1	Diabetes Mellitus 10/2023
1	Acne Vulgaris 09/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 04/2021 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2016
6	micheliolideIBA 01/2023 - 01/2019
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
4	Indicators and Reagents (Reagents)IBA 11/2023 - 08/2017
4	MicroRNAs (MicroRNA)IBA 05/2023 - 10/2019
4	ArsenicIBA 03/2023 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2022
3	CytokinesIBA 01/2024 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 09/2022
3	Particulate MatterIBA 06/2023 - 01/2023
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2019
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 10/2016
3	parthenolideIBA 12/2022 - 01/2020
3	LipidsIBA 08/2022 - 01/2022
3	Hormones (Hormone)IBA 01/2022 - 01/2017
3	dimethylaminomicheliolideIBA 12/2019 - 01/2019
2	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 09/2022
2	Retinaldehyde (Retinal)IBA 01/2024 - 10/2023
2	afliberceptIBA 01/2024 - 01/2023
2	CateninsIBA 11/2023 - 01/2021
2	Ion Channels (Ion Channel)IBA 10/2023 - 01/2023
2	Therapeutic UsesIBA 12/2022 - 09/2022
2	CollagenIBA 12/2022 - 11/2020
2	HirudinsIBA 12/2022 - 11/2022
2	Metal-Organic FrameworksIBA 12/2022 - 01/2022
2	AnticoagulantsIBA 11/2022 - 11/2018
2	EnzymesIBA 09/2022 - 01/2021
2	Annexin A5IBA 07/2022 - 03/2022
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 09/2019
2	Circular RNAIBA 01/2021 - 11/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 01/2020
2	ProteomeIBA 09/2020 - 05/2015
2	ProdrugsIBA 12/2019 - 01/2019
2	Thalidomide (Thalomid)FDA Link 10/2019 - 10/2016
2	AngiomotinsIBA 01/2017 - 03/2016
2	Chemotactic FactorsIBA 02/2014 - 07/2013
1	salicylhydroxamic acid (SHAM)IBA 05/2024
1	niuhuang qingxinIBA 03/2024
1	PowdersIBA 03/2024
1	carboxymethyl-chitosanIBA 01/2024
1	Fibroins (Fibroin)IBA 01/2024
1	naringinIBA 01/2024
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2024
1	neuroligin 3IBA 01/2024
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2024
1	SiliconesIBA 11/2023
1	Advanced Oxidation Protein Products (AOPP)IBA 11/2023
1	Estrogens (Estrogen)FDA Link 11/2023
1	Uric Acid (Urate)IBA 10/2023
1	evolocumabIBA 10/2023
1	Carbon Nanotubes (Carbon Nanotube)IBA 09/2023
1	AcidsIBA 09/2023
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2023

Therapy/Procedure

19	Therapeutics 10/2023 - 03/2016
8	Drug Therapy (Chemotherapy) 04/2023 - 01/2017
7	Peritoneal Dialysis 02/2024 - 01/2019
3	Lasers (Laser) 01/2024 - 08/2018
3	Immunotherapy 10/2022 - 10/2016
2	Aftercare (After-Treatment) 01/2024 - 01/2023
2	Light Coagulation 01/2024 - 01/2023
2	Photothermal Therapy 12/2022 - 09/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024
1	Precision Medicine 12/2023
1	Dacryocystorhinostomy 11/2023